Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Virginia National Institutes of Health (NIH) |
---|---|
Information provided by: | University of Virginia |
ClinicalTrials.gov Identifier: | NCT00631553 |
The purpose of this study is to determine if contrast enhanced ultrasound (CEU) using microbubbles, is useful in assessing changes in kidney blood flow.
Condition | Intervention |
---|---|
Kidney |
Drug: perflutren lipid microspheres |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kambiz Kalantarinia, MD | 434 924 5125 | kk6c@virginia.edu |
Contact: Lori Ratliff, RN ANP | 434 924 5820 ext 4-1572 | lbr@virginia.edu |
United States, Virginia | |
University of Virginia Health System | Recruiting |
Charlottesville, Virginia, United States, 22908 | |
Contact: Kalantarinia kk6cQ@virginia.edu | |
Contact: Ratliff lbr@virgina.edu | |
Principal Investigator: Kambiz Kalantarinia, MD |
Principal Investigator: | Kambiz Kalantarinia, MD | University of Virginia |
Responsible Party: | University of Virginia Dept of Medicine ( Kambiz Kalantarinia MD Assitant Professor of Medicine ) |
Study ID Numbers: | 12014 |
Study First Received: | February 27, 2008 |
Last Updated: | August 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00631553 |
Health Authority: | United States: Food and Drug Administration |